1. Market Research
  2. > Pharmaceutical Market Trends
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand

  • April 2018
  • 117 pages
  • ID: 5399423
  • Format: PDF
  • GlobalData

Summary

Table of Contents

Search Inside

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand

Summary
New Zealand is a mature healthcare market with a strong regulatory environment.The largest and fastest growing segment of biologics is monoclonal antibodies, which accounts for around $110m per annum.

It spends approximately 11% of its GDP on healthcare.In 2015, the pharmaceutical sales declined to around $688m from around $796m in 2014.

This again rose to around $746 in 2016.The market is forecast to grow to and cross $1 billion in 2022; at a CAGR of around 6%.

In 2010, the medical device market in New Zealand was worth about $1.17 billion, which increased to around $1.4 billion in 2017. It is expected to grow at a CAGR of about 3.4% from around $1.5 billion in 2018 to $1.8 billion in 2022.

The main segments were ophthalmic devices, wound care management, healthcare IT, orthopedic devices and in vitro diagnostics.The increasing elderly population and high investment in R&D expenditure are expected to drive the growth of pharmaceutical market.

However, high penetration of generics in the market and the policies of PHARMAC, pose as a barrier for the multinational pharmaceutical manufacturers

The government of New Zealand encourages innovation and supports biomedical and drug development research with continuous investment in science, research and technology as a mechanism to increase the knowledge economy.

The report "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - New Zealand", provides information on the healthcare, regulatory, and reimbursement landscape in New Zealand, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Douglas, Mylan, GSK, Merck and NZP) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, DePuy Synthes, Essilor and Fisher & Paykel Healthcare)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of New Zealand
- Porter’s five forces analysis for pharmaceutical and medical devices market of New Zealand
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the New Zealand healthcare market

Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in New Zealand, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Douglas, Mylan, GSK, Merck and NZP) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, DePuy Synthes, Essilor and Fisher & Paykel Healthcare)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of New Zealand
- Porter’s five forces analysis for pharmaceutical and medical devices market of New Zealand
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the New Zealand healthcare market.

Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the New Zealand healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the New Zealand healthcare market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Track and Trace Solutions Market by Product, Technology, Application, End User - Global Forecast to 2026

  • $ 4950
  • May 2021
  • 320 pages

The implementation of track and trace solutions and technologies is an important strategy adopted by many manufacturing companies and regulatory bodies in recent years. The global track and trace solutions ...

  • Europe
  • World
  • Pharmaceutical
  • Medical Device
  • Industry analysis
  • Health Expenditure
  • Pharmaceutical Production

ref:plp2018

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on